[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
August 25, 2015

Fusing Randomized Trials With Big DataThe Key to Self-learning Health Care Systems?

Author Affiliations
  • 1Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
  • 2Associate Editor, JAMA
JAMA. 2015;314(8):767-768. doi:10.1001/jama.2015.7762

Randomized clinical trials (RCTs) have revolutionized medicine by providing evidence on the efficacy and safety of drugs, devices, and procedures. Today, more than 40 000 RCTs are reported annually, their quality continues to increase, and oversight mechanisms ensure adequate protection of participants. However, RCTs have at least 4 related problems: (1) they are too expensive and difficult; (2) their findings are too broad (average treatment effect not representative of benefit for any given individual) and too narrow (trial population and setting not representative of general practice); (3) randomizing patients can make patients and physicians uncomfortable, especially when comparing different types of existing care; and (4) there are often long delays before RCT results diffuse into practice.

First Page Preview View Large
First page PDF preview
First page PDF preview
×